ATE119937T1 - Die alpha- oder beta-ketten von inhibin codierende nukleinsäure und verfahren zur synthese von polypeptiden unter verwendung einer solchen nukleinsäure. - Google Patents

Die alpha- oder beta-ketten von inhibin codierende nukleinsäure und verfahren zur synthese von polypeptiden unter verwendung einer solchen nukleinsäure.

Info

Publication number
ATE119937T1
ATE119937T1 AT86307586T AT86307586T ATE119937T1 AT E119937 T1 ATE119937 T1 AT E119937T1 AT 86307586 T AT86307586 T AT 86307586T AT 86307586 T AT86307586 T AT 86307586T AT E119937 T1 ATE119937 T1 AT E119937T1
Authority
AT
Austria
Prior art keywords
nucleic acid
alpha
inhibin
polypeptides
synthesis
Prior art date
Application number
AT86307586T
Other languages
English (en)
Inventor
Anthony John Mason
Peter Horst Seeburg
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27419805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE119937(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/906,729 external-priority patent/US4798885A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE119937T1 publication Critical patent/ATE119937T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
AT86307586T 1985-10-03 1986-10-02 Die alpha- oder beta-ketten von inhibin codierende nukleinsäure und verfahren zur synthese von polypeptiden unter verwendung einer solchen nukleinsäure. ATE119937T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78391085A 1985-10-03 1985-10-03
US82771086A 1986-02-07 1986-02-07
US06/906,729 US4798885A (en) 1986-02-07 1986-09-12 Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain

Publications (1)

Publication Number Publication Date
ATE119937T1 true ATE119937T1 (de) 1995-04-15

Family

ID=27419805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86307586T ATE119937T1 (de) 1985-10-03 1986-10-02 Die alpha- oder beta-ketten von inhibin codierende nukleinsäure und verfahren zur synthese von polypeptiden unter verwendung einer solchen nukleinsäure.

Country Status (11)

Country Link
EP (1) EP0222491B2 (de)
AT (1) ATE119937T1 (de)
AU (3) AU603775B2 (de)
CA (1) CA1341631C (de)
DE (1) DE3650267T3 (de)
ES (1) ES2072248T5 (de)
HK (1) HK1007332A1 (de)
IE (1) IE65795B1 (de)
IL (1) IL80218A (de)
LV (1) LV11485B (de)
NZ (2) NZ217727A (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218717B1 (de) * 1985-04-18 1998-07-15 Biotechnology Australia Pty. Ltd. Rekombinantes inhibin
AU610821B2 (en) * 1985-04-18 1991-05-30 Inhibin Pty Limited Recombinant inhibin
JPH0637520B2 (ja) * 1985-07-03 1994-05-18 味の素株式会社 ポリペプチド
US4740587A (en) * 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
AU599373B2 (en) * 1986-03-13 1990-07-19 Biotechnology Australia Proprietary Limited Method of assay of inhibin
US4973577A (en) * 1986-04-04 1990-11-27 The Salk Institute For Biological Studies FSH-releasing peptides
CA1302651C (en) * 1986-04-04 1992-06-02 Wylie Walker Vale, Jr. Fsh-releasing peptide
US5015729A (en) * 1986-06-24 1991-05-14 The Salk Institute For Biological Studies Ovine inhibin
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
EP0368992B1 (de) * 1988-05-31 1995-02-15 Biotechnology Australia Pty. Ltd. Wirkung von hormonen
US5071834A (en) * 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
US4997815A (en) * 1988-11-01 1991-03-05 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
AU7321891A (en) * 1990-02-15 1991-09-03 Cetus Corporation Inhibitor of cytokine activity and applications thereof
IL99867A0 (en) * 1991-10-27 1992-08-18 Yissum Res Dev Co Pharmaceutical compositions containing activin a
ATE238417T1 (de) 1991-11-04 2003-05-15 Inst Genetics Llc Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
US6171584B1 (en) 1992-02-12 2001-01-09 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Method of treatment with growth/differentiation factors of the TGF-β family
US7067637B1 (en) 1992-02-12 2006-06-27 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Antibody or antibody fragments specific for a protein of the TGF-β family
US7025959B1 (en) 1992-02-12 2006-04-11 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh MP121, a growth/differentiation factor of the TGF-β family
US5807713A (en) * 1992-02-12 1998-09-15 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung DNA encoding growth/differentiation factor
US6120760A (en) * 1992-02-12 2000-09-19 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Growth/differentiation factors of the TGF-β family
US5753612A (en) * 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
BR9406715A (pt) * 1993-05-12 1996-02-06 Genetics Inst Molécula de DNA isolada célula hospedeira vetor método para produzir uma proteina (BMP-11) polipeptideo de proteina-11 morfogenética de osso purificada (BMP-11) e molécula de DNA quimérica
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
DE69434651T2 (de) 1993-12-07 2007-03-08 Genetics Institute, Inc., Cambridge Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
US5658876A (en) * 1994-04-28 1997-08-19 The General Hospital Corporation Activin antagonists as novel contraceptives
FR2720069A1 (fr) * 1994-05-19 1995-11-24 Inst Nat Sante Rech Med Dérivés de facteurs de croissance et d'hormones de la superfamille des TGFB, procédé pour leur obtention et leurs applications biologiques.
IL114397A0 (en) * 1994-07-01 1995-10-31 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF-beta-family
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
EP1163365A4 (de) 1999-02-25 2002-11-20 Auckland Uniservices Ltd Diagnose und therapie von frühzeitigem eierstockversagen
PT1223990E (pt) 1999-10-15 2004-12-31 Fidia Advanced Biopolymers Srl Formulacoes de acido hialuronico para administracao de proteinas osteogenicas
TWI329129B (en) 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
EP1399023B1 (de) 2001-06-01 2008-04-30 Wyeth Zusammensetzungen für die systemische verabreichung von sequenzen, die für knochenmorphogenese-proteinen kodieren
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
AUPR638101A0 (en) 2001-07-13 2001-08-09 Bioa Pty Limited Composition and method for treatment of disease
AU2004272072B2 (en) 2003-09-12 2010-07-08 Etex Corporation Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
WO2005116052A2 (en) 2004-04-27 2005-12-08 Research Development Foundation ANTAGONISM OF TGF-β SUPERFAMILY RECEPTOR SIGNALING
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
WO2010144696A1 (en) 2009-06-11 2010-12-16 Burnham Institute For Medical Research Directed differentiation of stem cells
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica
CN108285903B (zh) * 2018-01-29 2021-03-12 国家卫生计生委科学技术研究所 一种特异性刺激抗原的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
AU5903986A (en) * 1985-04-18 1986-11-05 Biotechnology Australia Proprietary Limited Recombinant inhibin
AU610821B2 (en) * 1985-04-18 1991-05-30 Inhibin Pty Limited Recombinant inhibin
EP0218717B1 (de) * 1985-04-18 1998-07-15 Biotechnology Australia Pty. Ltd. Rekombinantes inhibin

Also Published As

Publication number Publication date
DE3650267T2 (de) 1995-10-05
DE3650267T3 (de) 2004-05-13
EP0222491B2 (de) 2003-08-13
IE65795B1 (en) 1995-11-15
ES2072248T3 (es) 1995-07-16
LV11485A (lv) 1996-08-20
LV11485B (en) 1996-12-20
AU6351286A (en) 1987-04-09
AU5465190A (en) 1990-11-29
AU5243393A (en) 1994-03-10
EP0222491A1 (de) 1987-05-20
HK1007332A1 (en) 1999-04-09
DE3650267D1 (de) 1995-04-20
EP0222491B1 (de) 1995-03-15
IL80218A (en) 1994-11-28
ES2072248T5 (es) 2004-05-01
NZ217727A (en) 1990-05-28
NZ231899A (en) 1991-07-26
AU603775B2 (en) 1990-11-29
CA1341631C (en) 2012-06-12
IE862618L (en) 1987-04-03

Similar Documents

Publication Publication Date Title
ATE119937T1 (de) Die alpha- oder beta-ketten von inhibin codierende nukleinsäure und verfahren zur synthese von polypeptiden unter verwendung einer solchen nukleinsäure.
DE3683460D1 (de) Nukleinsaeurensonde zur geschlechtsbestimmung vor der geburt.
DK0506825T3 (da) Rekombinante ekspressionsvektorer og oprensningsfremgangsmåder til Thermus thermophilus-DNA-polymerase
DE3783396D1 (de) Verfahren zur herstellung von bishomo-gamma-linolensaeure und eicosapentaensaeure.
DE3887806D1 (de) Verfahren und Reaktionsgefäss zur Herstellung von Alkylnitrit.
DE3784391D1 (de) Verfahren zur herstellung von eine oelloesliche substanz enthaltenden festen produkten.
DE3784392D1 (de) Verfahren zur herstellung von eine oelloesliche substanz enthaltenden festen produkten.
ES2054612T3 (es) Secuencias de adn que codifican para proteinas con actividad biologica de los inhibidores husi tipo-i y procedimientos tecnologicos geneticos para la preparacion de estas proteinas.
ATE113274T1 (de) Alkylaminalkoxyphenyl-derivate, verfahren zur verwendung und sie enthaltende zusammensetzungen.
DE3752066D1 (de) Verfahren zur Herstellung von substituierten Pyridinen
DE3879150D1 (de) Verfahren zur katalytischen hydratation von olefinen.
ATE41426T1 (de) Verfahren zur herstellung von triacetoxysilanen aus tris(amino)silanen.
DE3776173D1 (de) Verfahren zur herstellung von saeureamiden.
ATE79410T1 (de) Verfahren zur selektiven abmessung von aminosaeuren.
DE3775872D1 (de) Salicylsaeureamide, verfahren zu ihrer herstellung und ihre verwendung.
ATA315686A (de) Verfahren zum mischen von medien unterschiedlicher zaehigkeit
DE3888317D1 (de) Verfahren zur Herstellung von Phosphorsäurederivaten und Zwischenprodukten.
DE69003957D1 (de) Verfahren zur Herstellung von gereinigten, fetten Alkyldiethanolamiden, die daraus hergestellten Produkte und ihre Verwendung.
ATE77378T1 (de) Verfahren zur herstellung von carbonsaeureamiden.
AT397658B (de) Verfahren zur herstellung von nucleinsäurederivaten
NO911240D0 (no) Fremgangsmaate for spesifikk mangfoldiggjoering av nukleinsyretemplater og for bestemmelse av nukleinsyrer.
DE3785812D1 (de) Verfahren zur zuechtung von safranstigmageweben.
ZA867569B (en) Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid
DE3669877D1 (de) Verfahren zur herstellung von phosphorsaeurederivaten und zwischenprodukten.
DE3775684D1 (de) Verfahren zur herstellung von derivaten phosphinischer saeure und zwischenprodukte dafuer.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0222491

Country of ref document: EP

EELA Cancelled due to lapse of time